# Breakthrough - T1DM and Chronic Kidney Disease

> **NCT07592000** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Chicago** · enrollment: 10 (estimated)

## Conditions studied

- Diabete Type 1
- Chronic Kidney Disease

## Interventions

- **DRUG:** Tegoprubart
- **BIOLOGICAL:** Islet Cell Transplant

## Key facts

- **NCT ID:** NCT07592000
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-29
- **Primary completion:** 2030-01-31
- **Final completion:** 2030-01-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07592000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07592000, "Breakthrough - T1DM and Chronic Kidney Disease". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07592000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*